Chin Lee
Chief Tech/Sci/R&D Officer at ALLAKOS INC.
Net worth: 413 750 $ as of 30/05/2024
Chin Lee active positions
Companies | Position | Start | End |
---|---|---|---|
ALLAKOS INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Chin Lee
Former positions of Chin Lee
Companies | Position | Start | End |
---|---|---|---|
Abbott Biotech, Inc. | Corporate Officer/Principal | - | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - | - |
THERAVANCE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
CONNECT BIOPHARMA HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 28/02/2022 | - |
Training of Chin Lee
The University of North Carolina at Chapel Hill | Doctorate Degree |
Northwestern University | Graduate Degree |
Statistics
International
United States | 9 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
ALLAKOS INC. | Health Technology |
Private companies | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Abbott Biotech, Inc. |
- Stock Market
- Insiders
- Chin Lee
- Experience